2022

Hay, J. et al. (2022) PKCβ facilitates leukemogenesis in chronic lymphocytic leukaemia by promoting constitutive BCR-mediated signalling. Cancers, 14(23), 6006. (doi: 10.3390/cancers14236006) (PMID:36497487) (PMCID:PMC9735720)

2019

Hay, Jodie ORCID: https://orcid.org/0000-0002-2000-2578, Gilroy, Kathryn, Huser, Camille ORCID: https://orcid.org/0000-0002-3785-7556, Kilbey, Anna, Mcdonald, Alma, MacCallum, Amanda, Holroyd, Ailsa ORCID: https://orcid.org/0000-0001-8687-5286, Cameron, Ewan ORCID: https://orcid.org/0000-0001-8311-1491 and Neil, James C. ORCID: https://orcid.org/0000-0003-4447-8279 (2019) Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity. Journal of Cellular Biochemistry, 120(10), pp. 18332-18345. (doi: 10.1002/jcb.29143) (PMID:31257681) (PMCID:PMC6772115)

Cosimo, E. et al. (2019) AKT/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival. Clinical Cancer Research, 25(5), pp. 1574-1587. (doi: 10.1158/1078-0432.CCR-18-2036) (PMID:30559170) (PMCID:PMC6398589)

2018

Holroyd, Ailsa K. ORCID: https://orcid.org/0000-0001-8687-5286 and Michie, Alison M. ORCID: https://orcid.org/0000-0002-5404-475X (2018) The role of mTOR-mediated signaling in the regulation of cellular migration. Immunology Letters, 196, pp. 74-79. (doi: 10.1016/j.imlet.2018.01.015) (PMID:29408410)

2015

Nakagawa, R. et al. (2015) Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes. Haematologica, 100(4), pp. 499-510. (doi: 10.3324/haematol.2014.112276) (PMID:25616575) (PMCID:PMC4380723)

Articles

Hay, J. et al. (2022) PKCβ facilitates leukemogenesis in chronic lymphocytic leukaemia by promoting constitutive BCR-mediated signalling. Cancers, 14(23), 6006. (doi: 10.3390/cancers14236006) (PMID:36497487) (PMCID:PMC9735720)

Hay, Jodie ORCID: https://orcid.org/0000-0002-2000-2578, Gilroy, Kathryn, Huser, Camille ORCID: https://orcid.org/0000-0002-3785-7556, Kilbey, Anna, Mcdonald, Alma, MacCallum, Amanda, Holroyd, Ailsa ORCID: https://orcid.org/0000-0001-8687-5286, Cameron, Ewan ORCID: https://orcid.org/0000-0001-8311-1491 and Neil, James C. ORCID: https://orcid.org/0000-0003-4447-8279 (2019) Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity. Journal of Cellular Biochemistry, 120(10), pp. 18332-18345. (doi: 10.1002/jcb.29143) (PMID:31257681) (PMCID:PMC6772115)

Cosimo, E. et al. (2019) AKT/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival. Clinical Cancer Research, 25(5), pp. 1574-1587. (doi: 10.1158/1078-0432.CCR-18-2036) (PMID:30559170) (PMCID:PMC6398589)

Holroyd, Ailsa K. ORCID: https://orcid.org/0000-0001-8687-5286 and Michie, Alison M. ORCID: https://orcid.org/0000-0002-5404-475X (2018) The role of mTOR-mediated signaling in the regulation of cellular migration. Immunology Letters, 196, pp. 74-79. (doi: 10.1016/j.imlet.2018.01.015) (PMID:29408410)

Nakagawa, R. et al. (2015) Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKC subversion induces up-regulation of PKC II expression in B lymphocytes. Haematologica, 100(4), pp. 499-510. (doi: 10.3324/haematol.2014.112276) (PMID:25616575) (PMCID:PMC4380723)